Background CPAP reduces blood pressure (BP) in patients with symptomatic obstructive
sleep apnoea (OSA). Whether the same benefit is present in patients with minimally …

Purpose This study aimed to evaluate the 10-year adherence to and identify the predictors of
dropout from continuous positive airway pressure (CPAP) treatment for patients with …

Continuous positive airway pressure (CPAP) has been the standard treatment of obstructive
sleep apnoea/hypopnoea syndrome (OSA) for almost four decades. Though usually …

Background Previous, largely uncontrolled studies demonstrated the substantial effects of
continuous positive airway pressure ventilation (CPAP) on a variety of physiologic and …

Purpose Continuous positive airway pressure (CPAP) is the therapy of choice for the
treatment of obstructive sleep apnea (OSA). Not all patients can use CPAP therapy with …

Background: Obstructive sleep apnea (OSA) may lead to the development of hypertension
and therapy with continuous positive airway pressure (CPAP) can promote reduction in …

Pulmonary hypertension (PH) can occur in patients with obstructive sleep apnea (OSA) in
the absence of cardiac or lung disease. Data on the development and severity of PH, and …

Study objectives: To assess predictive factors of quality-of-life (QoL) improvement and
continuous positive airway pressure (CPAP) use in patients with sleep apnea-hypopnea …

Background: Obstructive sleep apnea is a prevalent condition with serious medical and
psychosocial consequences. Nasal continuous positive airway pressure (CPAP) is the …

Introduction Obstructive sleep apnea–hypopnea syndrome (OSAHS) is an emerging public
health concern. Although different treatments for OSAHS had been proposed, continuous …